Results 171 to 180 of about 14,579 (261)

uPAR deficiency triggers TGFβ1-mediated fibrotic remodeling in a cardiac perivascular-like microenvironment. [PDF]

Stem Cell Res Ther
Goltseva Y, Tsokolaeva Z, Beloglazova I, Stepanova V, Boldyreva M, Ratner E, Mazar A, Andreev A, Shiryaev A, Parfyonova Y, Dergilev K.   +10 more
europepmc   +1 more source

uPAR signaling is under par for the podocyte course [PDF]

Journal of Molecular Medicine, 2012
openaire   +2 more sources

Cholecystokinin A Receptor Knockdown Diminishes Colon Cancer Cell Invasive Potential via Modulation of Integrin/FAK, EMT, and uPA/uPAR/MMP2 Axis. [PDF]

Oncol Res
Lin CS, Hsu TW, Lee HL, Kao SH.
europepmc   +1 more source

Plasminogen activator inhibitor-1 as an oncologic target: biology, therapeutic inhibitors, and clinical translation. [PDF]

Front Oncol
Al Shaer NSH, Tleyjeh A, Al-Attas MA, Alibrahim JH, Khan MI, Yaqinuddin A.   +5 more
europepmc   +1 more source

Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) as a Biomarker of Neurodysfunction. [PDF]

Neuromolecular Med
de Rezende VL, Mathias K, Danielski LG, Barichello T, Petronilho F.   +4 more
europepmc   +1 more source

Correction: The receptor for urokinaseplasminogen activator uPAR controls plasticity of cancer cell movement in mesenchymal and amoeboid migration style. [PDF]

Oncotarget
Margheri F, Luciani C, Taddei ML, Giannoni E, Laurenzana A, Biagioni A, Chill xE A, Chiarugi P, Fibbi G, Rosso MD.   +9 more
europepmc   +1 more source

uPAR-targeted multimodal tracer for pre- and intraoperative imaging in cancer surgery [PDF]

, 2015
Martin C. Boonstra, Pieter B. A. A. van Driel, Danny M. van Willigen, Marieke A. Stammes, Hendrica A.J.M. Prevoo, Quirijn R.J.G. Tummers, Andrew P. Mazar, Freek J. Beekman, Peter J.K. Kuppen, Cornelis J.�H. van de Velde, Clemens W.G.M. Löwik, John V. Frangioni, Fijs W. B. van Leeuwen, Cornelis F.M. Sier, Alexander L. Vahrmeijer   +14 more
openalex   +1 more source

Biomarkers of standard criteria and marginal donor lungs during ex vivo lung perfusion: A comparative study. [PDF]

JHLT Open
Hu MA, Zhang ZL, Hoffmann RF, Gan CT, Verschuuren EAM, Van De Wauwer C, Leuvenink HGD, Erasmus ME.   +7 more
europepmc   +1 more source

The role of suPAR and related proteins in kidney, heart diseases, and diabetes. [PDF]

J Clin Invest
Reiser J, Hayek SS, Sever S.
europepmc   +1 more source

From in-silico QSAR modeling to in-vitro MTT assay: experimental validation of novel uPAR leads for triple-negative breast cancer (TNBC) and skin cancer. [PDF]

Sci Rep
Badukle H, Jawarkar RD, Shah U, Chaudhary S, Alzahrani AYA, Samad A, Al-Hussain SA, Al-Mutairi AA, Zaki MEA.   +8 more
europepmc   +1 more source